Clinical Trial Update: Safety and Efficacy of Intramuscular Electrotransfer of Plasmid AMEP in Patients Suffering From Advanced or Metastatic Melanoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating intramuscular electrotransfer of plasmid AMEP in patients with advanced or metastatic melanoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• AMEP plasmid (AMEP)

Snippet

Sponsor: Valerio Therapeutics | Conditions: Melanoma | Phase 1, Phase 2 | Status: WITHDRAWN